1844 related articles for article (PubMed ID: 32385277)
21. Prognostic impact of programmed death-ligand 1 expression in correlation with human leukocyte antigen class I expression status in stage I adenocarcinoma of the lung.
Hirai A; Yoneda K; Shimajiri S; Kuroda K; Hanagiri T; Fujino Y; Tanaka F
J Thorac Cardiovasc Surg; 2018 Jan; 155(1):382-392.e1. PubMed ID: 28711324
[TBL] [Abstract][Full Text] [Related]
22. Activation of PPARγ in Myeloid Cells Promotes Progression of Epithelial Lung Tumors through TGFβ1.
Sippel TR; Johnson AM; Li HY; Hanson D; Nguyen TT; Bullock BL; Poczobutt JM; Kwak JW; Kleczko EK; Weiser-Evans MC; Nemenoff RA
Mol Cancer Res; 2019 Aug; 17(8):1748-1758. PubMed ID: 31088909
[TBL] [Abstract][Full Text] [Related]
23. Small RNA sequencing reveals metastasis-related microRNAs in lung adenocarcinoma.
Daugaard I; Venø MT; Yan Y; Kjeldsen TE; Lamy P; Hager H; Kjems J; Hansen LL
Oncotarget; 2017 Apr; 8(16):27047-27061. PubMed ID: 28460486
[TBL] [Abstract][Full Text] [Related]
24. Lung adenocarcinoma pathology stages related gene identification.
Sun GZ; Zhao TW
Math Biosci Eng; 2019 Oct; 17(1):737-746. PubMed ID: 31731374
[No Abstract] [Full Text] [Related]
25. High-dimensional single cell mapping of cerium distribution in the lung immune microenvironment of an active smoker.
Rahman AH; Lavin Y; Kobayashi S; Leader A; Merad M
Cytometry B Clin Cytom; 2018 Nov; 94(6):941-945. PubMed ID: 28734132
[TBL] [Abstract][Full Text] [Related]
26. T-cell exhaustion interrelates with immune cytolytic activity to shape the inflamed tumor microenvironment.
Cai MC; Zhao X; Cao M; Ma P; Chen M; Wu J; Jia C; He C; Fu Y; Tan L; Xue X; Yu Z; Zhuang G
J Pathol; 2020 Jun; 251(2):147-159. PubMed ID: 32222046
[TBL] [Abstract][Full Text] [Related]
27. LncRNA TTN-AS1 drives invasion and migration of lung adenocarcinoma cells via modulation of miR-4677-3p/ZEB1 axis.
Zhong Y; Wang J; Lv W; Xu J; Mei S; Shan A
J Cell Biochem; 2019 Oct; 120(10):17131-17141. PubMed ID: 31173403
[TBL] [Abstract][Full Text] [Related]
28. Targeting the Complement Pathway as a Therapeutic Strategy in Lung Cancer.
Kleczko EK; Kwak JW; Schenk EL; Nemenoff RA
Front Immunol; 2019; 10():954. PubMed ID: 31134065
[TBL] [Abstract][Full Text] [Related]
29. Metastasis suppressor 1 (MTSS1) expression is associated with reduced in-vivo metastasis and enhanced patient survival in lung adenocarcinoma.
Taylor MD; Bollt O; Iyer SC; Robertson GP
Clin Exp Metastasis; 2018 Feb; 35(1-2):15-23. PubMed ID: 29218652
[TBL] [Abstract][Full Text] [Related]
30. Digital Inference of Immune Microenvironment Reveals Low-Risk Subtype of Early Lung Adenocarcinoma.
Kurbatov V; Balayev A; Saffarzadeh A; Heller DR; Boffa DJ; Blasberg JD; Lu J; Khan SA
Ann Thorac Surg; 2020 Feb; 109(2):343-349. PubMed ID: 31568747
[TBL] [Abstract][Full Text] [Related]
31. Infiltration of tumor-associated macrophages is involved in tumor programmed death-ligand 1 expression in early lung adenocarcinoma.
Shima T; Shimoda M; Shigenobu T; Ohtsuka T; Nishimura T; Emoto K; Hayashi Y; Iwasaki T; Abe T; Asamura H; Kanai Y
Cancer Sci; 2020 Feb; 111(2):727-738. PubMed ID: 31821665
[TBL] [Abstract][Full Text] [Related]
32. Impact of T-cell receptor and B-cell receptor repertoire on the recurrence of early stage lung adenocarcinoma.
Liu J; Yang X; Lu X; Zhang L; Luo W; Cheng Y; Zhang L; Yang Y; Dai N; Xu Y; Guan Y; Xiao H; Li M; Wang D
Exp Cell Res; 2020 Sep; 394(2):112134. PubMed ID: 32540399
[TBL] [Abstract][Full Text] [Related]
33. Reverse engineering a predictive signature characterized by proliferation, DNA damage, and immune escape from stage I lung adenocarcinoma recurrence.
Yao J; Xue X; Qu D; Westphalen CB; Ge Y; Zhang L; Li M; Gao T; Chandrakesan P; Vega KJ; Peng J; An G; Weygant N
Acta Biochim Biophys Sin (Shanghai); 2020 Jun; 52(6):638-653. PubMed ID: 32395755
[TBL] [Abstract][Full Text] [Related]
34. IFN-γ-mediated inhibition of lung cancer correlates with PD-L1 expression and is regulated by PI3K-AKT signaling.
Gao Y; Yang J; Cai Y; Fu S; Zhang N; Fu X; Li L
Int J Cancer; 2018 Aug; 143(4):931-943. PubMed ID: 29516506
[TBL] [Abstract][Full Text] [Related]
35. EGFR E746-A750 deletion in lung cancer represses antitumor immunity through the exosome-mediated inhibition of dendritic cells.
Yu S; Sha H; Qin X; Chen Y; Li X; Shi M; Feng J
Oncogene; 2020 Mar; 39(13):2643-2657. PubMed ID: 32001818
[TBL] [Abstract][Full Text] [Related]
36. Overexpression of P4HA1 Is Correlated with Poor Survival and Immune Infiltrates in Lung Adenocarcinoma.
Zhou H; He Y; Li L; Wu C; Hu G
Biomed Res Int; 2020; 2020():8024138. PubMed ID: 33299876
[TBL] [Abstract][Full Text] [Related]
37. APE1 stimulates EGFR-TKI resistance by activating Akt signaling through a redox-dependent mechanism in lung adenocarcinoma.
Lu GS; Li M; Xu CX; Wang D
Cell Death Dis; 2018 Oct; 9(11):1111. PubMed ID: 30382076
[TBL] [Abstract][Full Text] [Related]
38. A novel circular RNA, circXPO1, promotes lung adenocarcinoma progression by interacting with IGF2BP1.
Huang Q; Guo H; Wang S; Ma Y; Chen H; Li H; Li J; Li X; Yang F; Qiu M; Zhao S; Wang J
Cell Death Dis; 2020 Dec; 11(12):1031. PubMed ID: 33268793
[TBL] [Abstract][Full Text] [Related]
39. A seven-long noncoding RNA signature predicts relapse in patients with early-stage lung adenocarcinoma.
Zhou H; Zhang H; Chen J; Cao J; Liu L; Guo C; Huang G; Zeng D
J Cell Biochem; 2019 Sep; 120(9):15730-15739. PubMed ID: 31050375
[TBL] [Abstract][Full Text] [Related]
40. Clinical significance and inflammatory landscapes of a novel recurrence-associated immune signature in early-stage lung adenocarcinoma.
Zhang C; Zhang Z; Zhang G; Zhang Z; Luo Y; Wang F; Wang S; Che Y; Zeng Q; Sun N; He J
Cancer Lett; 2020 Jun; 479():31-41. PubMed ID: 32201203
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
